Background

The problem with antidepressants

Research has shown that more than 50% of patients discontinue their antidepressant treatment before the recommended 6-month period without consulting their physician or pharmacist. Therefore, it is difficult to propose a more suitable treatment. Consequently, patient follow-up is compromised as well as their well-being.

  • Pilot Study Results

  • Project

    PERSISTANCE is a disease management program designed to optimize the use of treatments for chronic diseases. The available program, at the moment, concerns antidepressants for the treatment of depression or anxiety.

    Wellness and Disease Management (DM) programs can help employers and insurers to control costs, while optimizing the health outcomes of their employees.

    In the past, companies implemented health and wellness programs on a voluntary basis. However, with such initiatives it is important to evaluate their efficacy as well as their return on investment.



    For further information, please contact us at 514-284-4884 or 1-888-984-4884 or by email at info@persistance.ca

    PERSISTANCE is conducted with the help of an electronic data capture platform on a high-security server provided by Dacima Software Inc. The platform is 21 CFR Part 11 compliant.www.dacimasoftware.com

    Useful link: www.revivre.org